Financials

  • Market Capitalization 8.04 B
  • Employee 691
  • Founded 2014
  • CEO Rich Adcock
  • Website www.immunitybio.com
  • Headquarter Delaware, United States
  • FIGI BBG007T9DYW9
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-9.02
市销率
51.72

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
1030
PCVX
Vaxcyte, Inc. - Common Stock
56.38 USD+0.30%-2.66%+13.74%+33.29%8.14 B USD
1032
IMVT
Immunovant, Inc. - Common Stock
39.44 USD+1.73%-1.42%+18.76%+105.31%8.10 B USD
1057
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
61.94 USD-0.06%-3.92%+18.66%+56.24%7.74 B USD
1077
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
109.56 USD-0.36%-2.47%+20.48%-0.68%7.51 B USD

新闻